Nanovis
Nanovis is a unique technology company that discovers, develops, and commercializes innovative nanotechnology platforms designed for improving bone growth and fighting infection. Nanovis's bioceramic nanotube surface is FDA cleared with a differentiated label, is well-proven and is ready to upgrade any orthopedic implant made of titanium or titanium alloy. Nanovis's Nano FortiCore interbodies also utilize a deeply porous titanium scaffold (licensed from Sites Medical). Nanovis's advanced bioceramic bactericidal nanotube surface technology is in pre-clinical studies, and Nanovis's breakthrough localized infection technology targeting multi drug resistant bacteria is in pre-clinical studies.
About Nanovis
Founded
2008Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$10MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
384Location
City
Columbia CityState
IndianaCountry
United StatesNanovis
Find your buyer within Nanovis